Trial results posted: A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)

ClinicalTrials.gov records the first posting of results for study NCT04628494 on 2026-11-03. A registry posting does not establish that a treatment is effective or safe.

Why it matters

New trial results are available for scrutiny. This report describes the posting only; it does not evaluate the findings.

What remains uncertain

• The study findings have not been independently assessed by NULLPEN.

The source record

National Library of Medicine, National Institutes of Health